Shared on29 Aug 25Fair value Decreased 7.74%
Ramsay Health Care’s fair value has been revised downward as weakening net profit margins and a higher future P/E ratio have raised concerns over earnings growth and valuation, reducing the consensus analyst price target from A$41.31 to A$38.56. Valuation Changes Summary of Valuation Changes for Ramsay Health Care The Consensus Analyst Price Target has fallen from A$41.31 to A$38.56.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 0.37%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Increased 0.59%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.